176 related articles for article (PubMed ID: 26398657)
1. Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma.
Wu HB; Wang Z; Wang QS; Han YJ; Wang M; Zhou WL; Li HS
PLoS One; 2015; 10(9):e0137676. PubMed ID: 26398657
[TBL] [Abstract][Full Text] [Related]
2. Transtumoral targeting enabled by a novel neuropilin-binding peptide.
Roth L; Agemy L; Kotamraju VR; Braun G; Teesalu T; Sugahara KN; Hamzah J; Ruoslahti E
Oncogene; 2012 Aug; 31(33):3754-63. PubMed ID: 22179825
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and evaluation of
Dong P; Cai H; Chen L; Li Y; Yuan C; Wu X; Shen G; Zhou H; Zhang W; Li L
Contrast Media Mol Imaging; 2016 Nov; 11(6):467-474. PubMed ID: 27527756
[TBL] [Abstract][Full Text] [Related]
4. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
[TBL] [Abstract][Full Text] [Related]
5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
6. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
[TBL] [Abstract][Full Text] [Related]
7. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.
Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM
Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672
[TBL] [Abstract][Full Text] [Related]
8. Imaging integrin αvβ 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe.
Wu H; Chen H; Pan D; Ma Y; Liang S; Wan Y; Fang Y
Mol Imaging Biol; 2014 Dec; 16(6):781-92. PubMed ID: 25001194
[TBL] [Abstract][Full Text] [Related]
9. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide.
Chen X; Park R; Hou Y; Khankaldyyan V; Gonzales-Gomez I; Tohme M; Bading JR; Laug WE; Conti PS
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1081-9. PubMed ID: 15118844
[TBL] [Abstract][Full Text] [Related]
10. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
12. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
[TBL] [Abstract][Full Text] [Related]
13. Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts.
Kim EM; Park EH; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Kim K; Chung J
Nucl Med Biol; 2009 May; 36(4):371-8. PubMed ID: 19423004
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
15. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J
Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530
[TBL] [Abstract][Full Text] [Related]
16. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.
Shao G; Zhou Y; Wang F; Liu S
Mol Imaging; 2013; 12(1):39-48. PubMed ID: 23348790
[TBL] [Abstract][Full Text] [Related]
17. Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.
Lee FT; O'Keefe GJ; Gan HK; Mountain AJ; Jones GR; Saunder TH; Sagona J; Rigopoulos A; Smyth FE; Johns TG; Govindan SV; Goldenberg DM; Old LJ; Scott AM
J Nucl Med; 2010 Jun; 51(6):967-72. PubMed ID: 20484439
[TBL] [Abstract][Full Text] [Related]
18. A new molecular probe: An NRP-1 targeting probe for the grading diagnosis of glioma in nude mice.
Wu W; Zhong S; Gong Y; Shan Y; Yuan L; Wang L; Chen J; Zhang Z
Neurosci Lett; 2020 Jan; 714():134617. PubMed ID: 31705924
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of an
Yang X; Liu Z; Zhang H; Li Z; Munasinghe JP; Niu G; Teng G; Chen X
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):585-592. PubMed ID: 29285548
[TBL] [Abstract][Full Text] [Related]
20. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
